Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Front Endocrinol (Lausanne) ; 12: 665984, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33953702

RESUMEN

Background: Primary hyperparathyroidism (PHPT) and type 2 diabetes mellitus (T2DM) are common endocrine disorders impacting on skeletal health, whose concomitant occurrence is becoming more frequent. Patients and Methods: We searched the PubMed database from the National Library of Medicine about the relationship between T2DM and its treatment and bone manifestations of PHPT. Thereafter, we retrospectively evaluated a consecutive series of 472 PHPT patients. Among them 55 were also affected by T2DM. At the diagnosis of PHPT we compared bone turnover markers and bone densitometry between 55 patients with and 417 without T2DM and in the former group according to antidiabetic treatment. Results: Few data are available about T2DM and PHPT bone involvement, studies about T2DM treatments and PHPT bone manifestations are lacking. Among patients with PHPT of our series, those with T2DM were older, had a lower prevalence of osteitis fibrosa cystica, higher lumbar and femoral T-scores than the remaining patients. No difference was disclosed among the diabetic patients according to ongoing antidiabetic treatment, even though modern treatments were under-represented. Conclusions: No clinical study specifically evaluated the impact of T2DM on bone involvement in PHPT. In our experience, diabetic patients resulted more frequently "mild asymptomatic" than non-diabetic patients and showed a lower prevalence of radiological PHPT bone manifestations. The treatment of T2DM does not seem to affect the biochemical or clinical features of PHPT in our series. Further studies are needed to fully disclose the influence of T2DM and antidiabetic treatment on bone health in patients with PHPT.


Asunto(s)
Diabetes Mellitus Tipo 2/patología , Hiperparatiroidismo Primario/complicaciones , Osteítis Fibrosa Quística/patología , Anciano , Diabetes Mellitus Tipo 2/etiología , Femenino , Humanos , Masculino , Osteítis Fibrosa Quística/etiología , Pronóstico , Estudios Retrospectivos
2.
Endocr Pract ; 26(9): 983-989, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33471703

RESUMEN

OBJECTIVE: Clinically overt symptomatic bone disease in primary hyperparathyroidism (PHPT) is rarely seen today, and osteoporosis is the dominant finding. Subperiosteal bone resorption in the fingers and skull mottling are typical bone PHPT findings, the contemporary prevalence of which is unknown. We evaluated these mild lesions and investigated the impact of their occurrence on PHPT clinical management. METHODS: We evaluated retrospectively a monocentric series of 363 PHPT patients classified in Group 1 (n = 100) or Group 2 (n = 263) according to the presence or absence of bone involvement, respectively. Patients belonging to Group 1, in turn, were subdivided into Group 1A, with severe and symptomatic lesions (n = 48), and Group 1B, with milder signs of osteitis fibrosa cystica (OFC) without brown tumors or fractures (n = 52). RESULTS: Serum total and ionized calcium, parathyroid hormone, osteocalcin, alkaline phosphatase, and its bone fraction levels were higher in Group 1 than in Group 2, while no gender or age differences were observed between the groups. Osteoporosis prevalence was similar in Group 1B and Group 2 patients but lower than in Group 1A. Mild OFC findings did not modify the surgical indication in any patient of Group 1B. CONCLUSION: Minor radiologic signs of OFC are not uncommon in the modern PHPT phenotype and occur in patients with more active disease. These signs could identify PHPT patients in an earlier stage of typical bone involvement. However, these features do not seem to upgrade either the clinical classification of asymptomatic PHPT patients or the propensity toward surgical choice.


Asunto(s)
Hiperparatiroidismo Primario , Osteítis Fibrosa Quística , Densidad Ósea , Calcio , Humanos , Hiperparatiroidismo Primario/complicaciones , Hiperparatiroidismo Primario/diagnóstico por imagen , Hiperparatiroidismo Primario/epidemiología , Osteítis Fibrosa Quística/diagnóstico por imagen , Osteítis Fibrosa Quística/epidemiología , Osteítis Fibrosa Quística/etiología , Hormona Paratiroidea , Prevalencia , Estudios Retrospectivos
4.
Intern Med ; 54(7): 777-83, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25832941

RESUMEN

Hepatitis C-associated osteosclerosis (HCAO) is an uncommon condition characterized by increased bone density, skeletal pain and elevated bone formation markers. Since 1992, only 17 cases have been reported. We herein describe the case of a 61-year-old woman affected by severe pain involving the lower limbs. The laboratory data showed an elevated serum alkaline phosphatase level, and the patient was found to be seropositive for hepatitis C virus infection. In addition, an X-ray skeleton survey showed marked cortical thickening of both femurs and tibias, and a whole-body bone scan revealed an increased cortical radionuclide uptake in the involved bones. These findings were consistent with a diagnosis of HCAO. In this report, we discuss the patient's clinical course over 16 years and, for the first time, show a normalized radioisotope uptake on bone scanning 10 years after the diagnosis.


Asunto(s)
Fémur/patología , Hepacivirus/aislamiento & purificación , Hepatitis C/diagnóstico , Osteosclerosis/diagnóstico , Dolor/patología , Tibia/patología , Densidad Ósea , Progresión de la Enfermedad , Femenino , Fémur/diagnóstico por imagen , Estudios de Seguimiento , Hepatitis C/complicaciones , Hepatitis C/fisiopatología , Humanos , Persona de Mediana Edad , Osteosclerosis/diagnóstico por imagen , Osteosclerosis/fisiopatología , Dolor/etiología , Cintigrafía , Tibia/diagnóstico por imagen , Resultado del Tratamiento , Imagen de Cuerpo Entero
5.
Thromb Res ; 134(1): 84-9, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24837252

RESUMEN

INTRODUCTION: Venous thromboembolism (VTE) is a common vascular disease that results in deep venous thrombosis (DVT) and pulmonary embolism (PE). Factor V Leiden mutation (FVL) and G20210A prothrombin mutation (PTM) are associated with an increased risk of VTE. Recent studies have reported a lower prevalence of FVL in patients with isolated PE than in patients with DVT with or without PE, suggesting the possibility that the prevalence of FVL in patients with isolated PE may be not significantly different from that of the general population. To address this issue, we performed a systematic review and a meta-analysis of published studies that assessed the prevalence of FVL and/or PTM in patients with isolated PE and in controls without VTE. METHODS: MEDLINE and EMBASE databases were searched up to October 2013. Pooled odds Ratios (OR) and 95% confidence intervals (CIs) were calculated using a random-effects model. Statistical heterogeneity was evaluated using the Cochran Q and I(2) statistics. RESULTS: Eighteen studies totalling more than 11,000 patients were included. FVL was found significantly more often in patients presenting isolated PE than in controls (OR 2.06; 95% CI 1.66, 2.56; p <0.0001). The prevalence of PTM was also significantly different in patients presenting with isolated PE than in controls (OR 2.64, 95% CI 1.92, 3.63; p<0.0001). Heterogeneity among studies was low. CONCLUSION: FVL and PTM are both associated with isolated PE. However, the association magnitude between PE and FVL mutation appeared to be lower compared to that observed in the general population of VTE patients.


Asunto(s)
Factor V/genética , Embolia Pulmonar/genética , Trombofilia/genética , Estudios de Casos y Controles , Humanos , Estudios Prospectivos , Factores de Riesgo
6.
Lancet Infect Dis ; 13(11): 987-93, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24156899

RESUMEN

We present a case of hepatic abscess caused by Brucella melitensis (or hepatic brucelloma) diagnosed in a 59-year-old man 33 years after an episode of acute brucellosis that had completely resolved. Recovery from symptoms and a decrease in lesion size seen on radiological assessment were achieved through prolonged combined antibiotic therapy, without the need for surgery. Hepatic brucelloma is a rare complication of brucellosis, which is the most common zoonosis globally, mainly occurring in specific endemic areas and causing a range of clinical manifestations. In this Grand Round, we review the clinical manifestations, diagnostic approach (through laboratory, radiology, and histology findings), differential diagnosis, treatment, and prognosis of hepatic brucelloma.


Asunto(s)
Antibacterianos/uso terapéutico , Brucella melitensis/aislamiento & purificación , Brucelosis/microbiología , Absceso Hepático/microbiología , Zoonosis/microbiología , Animales , Brucelosis/diagnóstico por imagen , Brucelosis/tratamiento farmacológico , Humanos , Absceso Hepático/diagnóstico por imagen , Absceso Hepático/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Zoonosis/diagnóstico por imagen , Zoonosis/tratamiento farmacológico
8.
Thromb Haemost ; 109(1): 137-45, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23138420

RESUMEN

Duplex ultrasound is the first-line diagnostic test for detecting lower limb deep-vein thrombosis (DVT) but it is time consuming, requires patient transport, and cannot be interpreted by most physicians. The accuracy of emergency physician-performed ultrasound (EPPU) for the diagnosis of DVT, when performed at the bedside, is unclear. We did a systematic review and meta-analysis of the literature, aiming to provide reliable data on the accuracy of EPPU in the diagnosis of DVT. The MEDLINE and EMBASE databases (up to August 2012) were systematically searched for studies evaluating the accuracy of EPPU compared to either colour-flow duplex ultrasound performed by a radiology department or vascular laboratory, or to angiography, in the diagnosis of DVT. Weighted mean sensitivity and specificity and associated 95% confidence intervals (CIs) were calculated using a bivariate random-effects regression approach. There were 16 studies included, with 2,379 patients. The pooled prevalence of DVT was 23.1% (498 in 2,379 patients), ranging from 7.4% to 47.3%. Using the bivariate approach, the weighted mean sensitivity of EPPU compared to the reference imaging test was 96.1% (95%CI 90.6-98.5%), and with a weighted mean specificity of 96.8% (95%CI:94.6-98.1%). Our findings suggest that EPPU may be useful in the management of patients with suspected DVT. Future prospective studies are warranted to confirm these findings.


Asunto(s)
Competencia Clínica , Servicio de Urgencia en Hospital , Extremidad Inferior/irrigación sanguínea , Ultrasonografía Doppler Dúplex , Trombosis de la Vena/diagnóstico por imagen , Humanos , Sistemas de Atención de Punto , Valor Predictivo de las Pruebas , Prevalencia , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Ultrasonografía Doppler en Color , Ultrasonografía Doppler Dúplex/instrumentación , Trombosis de la Vena/epidemiología
9.
G Ital Nefrol ; 27 Suppl 50: S91-5, 2010.
Artículo en Italiano | MEDLINE | ID: mdl-20922703

RESUMEN

The kidney is one of the classical target organs of PTH action. Symptomatic primary hyperparathyroidism (PHPT) is nowadays less frequent but mostly occurs with renal symptoms, in particular kidney stones. Nephrocalcinosis and polyuria, the latter closely related to the severity of hypercalcemia, are uncommon. Parathyroidectomy leads to a marked and long-lasting improvement of nephrolithiasis, whereas it has a limited effect on nephrocalcinosis. Kidney failure is one of the long-term complications of PHPT and is associated with a more severe clinical expression of the disease and a higher risk of morbidity and mortality. Current guidelines on the management of asymptomatic PHPT, the most common presentation of PHPT today, recommend surgical treatment if renal function is decreased. However, in this particular clinical setting it is unclear whether PHPT is really associated with a more rapid decline of renal function or whether successful parathyroidectomy could protect renal function.


Asunto(s)
Hiperparatiroidismo Primario/fisiopatología , Riñón/fisiopatología , Humanos , Hiperparatiroidismo Primario/complicaciones , Enfermedades Renales/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA